ENZN
vs
S&P 500
ENZN
S&P 500
Over the past 12 months, ENZN has underperformed S&P 500, delivering a return of -30% compared to the S&P 500's +16% growth.
Stocks Performance
ENZN vs S&P 500
Performance Gap
ENZN vs S&P 500
Performance By Year
ENZN vs S&P 500
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Enzon Pharmaceuticals Inc
Glance View
Enzon Pharmaceuticals, Inc. is a biopharmaceutical company. The company is headquartered in Cranford, New Jersey and currently employs 0 full-time employees. The firm intends to become an acquisition platform. The firm utilizes its net operating loss carryforwards (NOLs) and improves stockholder value. The company manages its source of royalty revenues from existing licensing arrangements with other companies.